Creative Medical Technology Holdings, Inc. (CELZ) Stock Forecast & Price Target
Price as of Nov 18, 2026 close · Analyst estimates retrieved Nov 19, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Creative Medical Technology Holdings, Inc. (CELZ), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Creative Medical Technology Holdings, Inc., analysts forecast revenue rising from $3,000 in 2025 to $108.68M in 2030; the average estimate for 2030 earnings per share is $3.39; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Creative Medical Technology Holdings, Inc. (CELZ) forecast — frequently asked questions
What are analysts forecasting for Creative Medical Technology Holdings, Inc.'s earnings?
The average analyst estimate for Creative Medical Technology Holdings, Inc. (CELZ) earnings per share in 2030 is 3.39, with individual estimates between 3.39 and 3.39.
How much revenue is Creative Medical Technology Holdings, Inc. expected to make?
Analysts forecast Creative Medical Technology Holdings, Inc. (CELZ) revenue of $108.68M in 2030, based on 1 published estimates.
How many analysts cover CELZ?
1 analyst contribute estimates for Creative Medical Technology Holdings, Inc. (CELZ). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.